Detalhe da pesquisa
1.
Rosiglitazone Reverses Inflammation in Epididymal White Adipose Tissue in Hormone-Sensitive Lipase-Knockout Mice.
J Lipid Res
; 64(1): 100305, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36273647
2.
Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial.
Diabetologia
; 66(8): 1413-1430, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308751
3.
Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes.
Diabetes Obes Metab
; 25(5): 1351-1360, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692230
4.
Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 2 diabetes.
Diabetes Obes Metab
; 25(12): 3716-3723, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37694740
5.
Empagliflozin in acute myocardial infarction: the EMMY trial.
Eur Heart J
; 43(41): 4421-4432, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036746
6.
A joint alignment and reconstruction algorithm for electron tomography to visualize in-depth cell-to-cell interactions.
Histochem Cell Biol
; 157(6): 685-696, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35318489
7.
Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy.
Diabetes Obes Metab
; 24(3): 455-464, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739179
8.
Differential In Vitro Effects of SGLT2 Inhibitors on Mitochondrial Oxidative Phosphorylation, Glucose Uptake and Cell Metabolism.
Int J Mol Sci
; 23(14)2022 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35887308
9.
Hyperinsulinaemic-hypoglycaemic glucose clamps in human research: a systematic review of the literature.
Diabetologia
; 64(4): 727-736, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33566134
10.
Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation.
Am J Pathol
; 190(2): 400-411, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31759969
11.
Survival assessment of the extended-wear insulin infusion set featuring lantern technology in adults with type 1 diabetes by the glucose clamp technique.
Diabetes Obes Metab
; 23(6): 1402-1408, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33528887
12.
Efficient and safe glycaemic control with basal-bolus insulin therapy during fasting periods in hospitalized patients with type 2 diabetes using decision support technology: A post hoc analysis.
Diabetes Obes Metab
; 23(9): 2161-2169, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34081386
13.
Adverse body composition and lipid parameters in patients with prolactinoma: a case-control study.
BMC Endocr Disord
; 21(1): 81, 2021 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33902531
14.
Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial.
Diabetologia
; 63(4): 698-710, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31984443
15.
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
N Engl J Med
; 377(8): 723-732, 2017 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28605603
16.
Development of a hypoglycaemia risk score to identify high-risk individuals with advanced type 2 diabetes in DEVOTE.
Diabetes Obes Metab
; 22(12): 2248-2256, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32996693
17.
Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE.
Diabetes Obes Metab
; 22(12): 2241-2247, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32250536
18.
Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14.
Cardiovasc Diabetol
; 18(1): 156, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31729990
19.
Short-term cost-utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9).
Diabetes Obes Metab
; 21(7): 1706-1714, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30924579
20.
Fast-acting insulin aspart in people with type 2 diabetes: Earlier onset and greater initial exposure and glucose-lowering effect compared with insulin aspart.
Diabetes Obes Metab
; 21(9): 2068-2075, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31069935